Delray Medical Center announces the acquisition of the Exablate Prime system, a state-of-the-art technology that offers incisionless treatment for movement disorders such as essential tremor and Parkinson’s disease. This advanced platform utilizes focused ultrasound guided by MRI to precisely target and remove affected areas in the brain, providing patients with a non-invasive surgery option.
“The precision and safety of the Exablate Prime system represent a significant advancement in neurosurgery,” said Dr. Lloyd Zucker, Chief of Neurosurgery at Delray Medical Center. “By offering an outpatient, incisionless procedure, while utilizing some of the latest technologies, we can improve patient outcomes and reduce recovery times for those battling conditions like essential tremor.”
The Exablate Prime system, developed by Insightec, has transformed the landscape of neurosurgical treatments by providing a non-invasive alternative to traditional brain surgery. Patients typically experience immediate therapeutic effects with minimal complications, allowing them to return home the same day.
This next generation system integrates intelligent algorithms, autogenerated patient reports, data management, and reporting power to allow for advanced and intuitive surgical planning and sonification, which all makes the process faster and more accurate.
